David Burgoyne, Ph.D.

David Burgoyne, Ph.D.

Founder and CEO

Dr. David Burgoyne has over 20 years of experience in the business of drug discovery and early stage pharmaceutical development.

    John Langlands, Ph.D.

    John Langlands, Ph.D.

    Vice President Pre-Clinical Research

    Joining Naegis in the summer of 2013, Dr. John Langlands brings over 20 years of experience in the development of new pharmaceuticals.

      Dr. Peter Hnik, MD, MHSc

      Dr. Peter Hnik, MD, MHSc

      Clinical Advisor

      Dr. Peter Hnik received his medical degree from the Medical Faculty of Charles University of Prague in 1981.

        123
        Top
        We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…